14-47394632-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001113498.3(MDGA2):c.281-93082G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.72 in 152,020 control chromosomes in the GnomAD database, including 39,699 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.72 ( 39699 hom., cov: 32)
Consequence
MDGA2
NM_001113498.3 intron
NM_001113498.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.631
Publications
10 publications found
Genes affected
MDGA2 (HGNC:19835): (MAM domain containing glycosylphosphatidylinositol anchor 2) Predicted to be involved in regulation of presynapse assembly; regulation of synaptic membrane adhesion; and spinal cord motor neuron differentiation. Predicted to act upstream of or within neuron migration and pattern specification process. Predicted to be located in extracellular region and plasma membrane. Predicted to be active in GABA-ergic synapse and glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.759 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MDGA2 | NM_001113498.3 | c.281-93082G>A | intron_variant | Intron 1 of 16 | ENST00000399232.8 | NP_001106970.4 | ||
| MDGA2 | XM_011536522.4 | c.281-93082G>A | intron_variant | Intron 1 of 9 | XP_011534824.1 | |||
| MDGA2 | XM_047431051.1 | c.281-93082G>A | intron_variant | Intron 1 of 7 | XP_047287007.1 | |||
| MDGA2 | XM_017021061.3 | c.281-93082G>A | intron_variant | Intron 1 of 7 | XP_016876550.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.720 AC: 109409AN: 151900Hom.: 39674 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
109409
AN:
151900
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.720 AC: 109488AN: 152020Hom.: 39699 Cov.: 32 AF XY: 0.714 AC XY: 53046AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
109488
AN:
152020
Hom.:
Cov.:
32
AF XY:
AC XY:
53046
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
27292
AN:
41458
American (AMR)
AF:
AC:
11459
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
2842
AN:
3470
East Asian (EAS)
AF:
AC:
3175
AN:
5168
South Asian (SAS)
AF:
AC:
2607
AN:
4814
European-Finnish (FIN)
AF:
AC:
7516
AN:
10558
Middle Eastern (MID)
AF:
AC:
240
AN:
294
European-Non Finnish (NFE)
AF:
AC:
51988
AN:
67974
Other (OTH)
AF:
AC:
1594
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1568
3137
4705
6274
7842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.